[ad_1]
Denali Therapeutics Inc. (DNLI) Analyst/Investor Day December 4, 2025 8:30 AM EST
Firm Members
Ryan Watts – Co-Founder, President, CEO & Director
Peter Chin – Appearing Chief Medical Officer & Head of Improvement
Katie Peng – Chief Industrial Officer
Joe Lewcock – Chief Scientific Officer
Dana Andersen – Chief Technical and Manufacturing Officer
Alexander Schuth – Co-Founder, CFO, COO & Secretary
Carole Ho
Convention Name Members
Joseph Muenzer
Kim Stephens
Jason Madison
Sean Laaman – Morgan Stanley, Analysis Division
Barbara Burton
Salveen Richter – Goldman Sachs Group, Inc., Analysis Division
Thomas Shrader – BTIG, LLC, Analysis Division
Ananda Ghosh – H.C. Wainwright & Co, LLC, Analysis Division
Madison Wynne El-Saadi – B. Riley Securities, Inc., Analysis Division
John Cox – Jefferies LLC, Analysis Division
Joseph Thome – TD Cowen, Analysis Division
Charles Moore – Robert W. Baird & Co. Included, Analysis Division
Huidong Wang – Barclays Financial institution PLC, Analysis Division
Julian Pino – Stifel, Nicolaus & Firm, Included, Analysis Division
Cheng Li – Oppenheimer & Co. Inc., Analysis Division
Dialog
Ryan Watts
Co-Founder, President, CEO & Director
Our Investor Day. We have been excited to share an replace. I feel usually, I am sitting in a fireplace chat with lots of you. So it is nice to see your faces right here. We’ll go into some depth right this moment about what we’re doing at Denali. And I feel it is a distinctive alternative for us to actually set the stage for what the long run appears to be like like for Denali, however then dive into some questions.
We even have some actually necessary company with us, which I am going to introduce later from the lysosomal storage illness group. So these are our forward-looking statements, and let’s dive in. Let’s begin with the important thing messages. So our function at Denali is to ship the facility of biotherapeutics to the entire physique, together with the mind.
It is a little completely different than what we have stated perhaps within the final 5 or
[ad_2]
